CRLComplete Response Letter
Complete Response Letter Astellas Pharma US, Inc. (Aug 28, 2017)
FDA's complete response letter contains source-text evidence related to Chemistry, manufacturing, and controls. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• VESICARE LS
